Our Team
David Henderson is a highly successful global biotechnology executive with an extensive background in commercial operations and finance. David focuses on therapeutic areas including rare diseases, oncology, immunology, and specialty biologics. He has experience with all product lifecycle stages, from pipeline to launch, through growth and maturity, to decline associated with generics and branded competition. …
Read More